Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Vagus nerve stimulation Stories

2011-11-01 08:00:00

HOUSTON, Nov. 1, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the second quarter ended October 28, 2011 of its fiscal year ending April 27, 2012, on Friday, November 18, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2012 Second Quarter Results Conference Call Instructions The...

2011-10-31 08:00:00

HOUSTON, Oct. 31, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration ("FDA") approved a significant expansion of options for Magnetic Resonance Imaging ("MRI") use by patients who have the VNS Therapy System. The expansion includes: New: All cylindrical MRI scanners with magnetic field strengths of 3.0 and 1.5 Tesla; Previous: GE Signa...

2011-10-27 07:47:00

ST. PAUL, Minn., Oct. 27, 2011 /PRNewswire/ -- Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation (HGNS®) System for use by people who suffer from obstructive sleep apnea (OSA). The system was approved for sale in Europe based on the positive results of two clinical studies conducted in the United States and Australia. In those studies, the majority of patients demonstrated a significant reduction in their obstructive sleep apnea as...

2011-10-05 15:00:00

HOUSTON, Oct. 5, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced an initial investment of $4 million in ImThera Medical, Inc. ("ImThera"). Based in San Diego, California, ImThera is an early-stage company developing a novel, implantable neurostimulation device for the treatment of obstructive sleep apnea ("OSA"). The investment in ImThera can total $12 million subject to the...

2011-09-13 08:00:00

HOUSTON, Sept. 13, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 Credit Suisse Small and Mid Cap & Future of Energy Conference on Tuesday, September 27, 2011, in New York. Greg Browne, Cyberonics' Senior Vice President and Chief Financial Officer, will speak to the attendees of the conference at 10:40 AM Eastern Time. This session will not be webcast. Presentation materials can be accessed...

2011-09-07 08:00:00

HOUSTON, Sept. 7, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 UBS Global Life Sciences Conference on Wednesday, September 21, 2011, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference 10:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics...

2011-08-25 15:00:00

HOUSTON, Aug. 25, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced that it will participate in the 2011 Baird Healthcare Conference on Thursday, September 8, 2011, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference at 2:15 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics...

2011-08-15 07:00:00

HOUSTON, Aug. 15, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in devices for epilepsy management, announced today that it has voluntarily stopped shipment and is retrieving field inventory of its Aspire platform generators, Models 105 and 106. The company does not believe that the generators pose a health risk to patients, but initiated this action when it discovered that stimulation output current delivered to patients can be less than the output current...

2011-08-12 06:53:03

(Ivanhoe Newswire) -- There may be a new treatment for obstructive sleep apnea (OSA) on the horizon. Researchers have received approval from the FDA to begin a clinical trial to evaluate an investigational device known as the Hypoglossal Nerve Stimulation (HGNS) System. According to the World Health Organization, about 100 million people worldwide suffer from OSA. It happens because of a blockage of breathing during sleep, which can deprive patients of deep sleep and lead to a variety of...

2011-08-09 08:00:00

HOUSTON, Aug. 9, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the first quarter ended July 29, 2011 of its fiscal year ending April 27, 2012, on Thursday, August 25, 2011, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2012 First Quarter Results Conference Call Instructions The...